Sodium Thiosulfate Effectively Reduces Toxicity and Improves Survival Rate

Published: 2005-04-15 06:58:00

Updated: 2005-04-15 06:58:00

The clinical study conducted by a team of researchers from the United States shows that sodium thiosulfate, a chemoprotective agent, effectively reduced toxicity and thus enabled dose escalation of antineoplastic cisplatin therapy performed with concomitant radiation therapy for patients with adv...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK